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Introduction
Hydroxyapatite (HAp) Ca10(PO4)6(OH)2 characteristics relevant to
bone replacement application, like bioactivity, biocompatibility and
solubility, are directly influenced by particles properties
Several methods have been used to synthesize HAp. Among them,
precipitation is of significant interest because of its simplicity, low cost,
and easy application in industrial production
Difficulties have been encountered in producing stoichiometric HAp at
physiological conditions due to the complexity of the calcium
phosphate system (Fig1), the structure of HAp particularly prone to ion
substitution and the role of the kinetic factors
At the moment, the systems available for HAp production do not
guarantee the stoichiometrical equilibrium, mainly due to the way
reagents are mixed. This calls for the development of a system that
provides an efficient and intense mixing. In that way, the oscillatory
flow reactor (OFR) appears as a good candidate to promote ideal
conditions for the controllability of HAp particles properties
Objectives
The present project aims at precipitating HAp crystals at 37ºC with a
carefully controlled size, with a controlled and narrow size distribution
and with a high purity, making them suitable for application in bone
substitution
Figure 1. Solubility isotherms of calcium phosphates in the 
system Ca(OH)2-H3PO4-H2O at 37ºC (Elliot, 1994).
Results
HAp precipitation was carried out in a 1L stirred tank reactor (Fig2a)
mixing a calcium aqueous solution and a phosphate aqueous solution
During HAp precipitation, pH was continuously measured revealing
the occurrence of three stages (Fig3). In those stages the product was
characterized through SEM analysis
The final product was analyzed by X-ray diffraction which confirmed it
to be HAp (Fig4)
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Work plan
 HAp precipitation process:
Optimization of the operation conditions and modelling of the HAp                
crystallization process
 Bone extracellular matrix growth:
Biological validation of the processes and the products 
developed
Figure 2. a) Experimental crystallization apparatus, b) OFR 
developed by CEB-UMinho (Reis et al., 2005).
Figure 3. pH evolution during HAp precipitation and SEM images of the 
product developed at the different pH stages.
Figure 4. X-ray diffraction diagram corresponding
to the final product of HAp precipitation. 
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